Cargando…

Cardiogoniometry as a diagnostic tool in patients with acute coronary syndromes: results of the CGM@ACS trial

BACKGROUND: Cardiogoniometry (CGM) is a novel electrocardiac method utilising computer-assisted three-dimensional information on cardiac potentials. OBJECTIVE: To investigate the potential of CGM in discriminating non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and relevant coronary sten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tölg, Ralph, Zeymer, Uwe, Birkemeyer, Ralf, Wessely, Rainer, Eggebrecht, Holger, Bocksch, Wolfgang, Schneider, Steffen, Richardt, Gert, Hamm, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426668/ https://www.ncbi.nlm.nih.gov/pubmed/22485015 http://dx.doi.org/10.1007/s00392-012-0452-2

Ejemplares similares

Accuracy of Cardiogoniometry Compared With Electrocardiography in the Diagnosis of Coronary Artery Disease
por: Ghadrdoost, Behshid, et al.
Publicado: (2015)

Cardiogoniometry Compared to Fractional Flow Reserve at Identifying Physiologically Significant Coronary Stenosis: The CARDIOFLOW Study
por: Brown, Oliver I., et al.
Publicado: (2018)

Cardiogoniometry in psoriatic patients and its comparison with a control group
por: Poorzand, Hoorak, et al.
Publicado: (2017)

Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study
por: Kebernik, Julia, et al.
Publicado: (2018)

Cardiogoniometry can predict positive response to cardiac resynchronization therapy – A proof of concept study
por: Alizadehasl, Azin, et al.
Publicado: (2018)

Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial
por: Lawson, Margaret L., et al.
Publicado: (2020)

Ablation of typical atrial flutter as therapeutic component in carcinoid heart disease: a case report
por: Groschke, Susann, et al.
Publicado: (2022)

Comparison of Glucose Metrics Between Users of CGM Readers and CGM-Connected Apps
por: Kao, Kalvin, et al.
Publicado: (2021)

Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study
por: Zeymer, Uwe, et al.
Publicado: (2022)

CGM in the Hospital: Is It Ready for Prime Time?
por: Buschur, Elizabeth O., et al.
Publicado: (2022)

Oral Antiplatelet Therapy in Acute Coronary Syndromes: Recent Developments
por: Zeymer, Uwe
Publicado: (2013)

Management of the COVID-19 pandemic in Rhineland-Palatinate hospitals of all levels of care: Results of the COVID-19 Registry RLP
por: Gitt, Anselm K., et al.
Publicado: (2023)

Management of acute coronary syndromes with fondaparinux
por: Wienbergen, Harm, et al.
Publicado: (2007)

Effect of Acetaminophen on CGM Glucose in an Outpatient Setting
por: Maahs, David M., et al.
Publicado: (2015)

Sex Differences in Percutaneous Coronary Intervention—Insights From the Coronary Angiography and PCI Registry of the German Society of Cardiology
por: Heer, Tobias, et al.
Publicado: (2017)

CGM and CGI: metafile and interface standards for computer graphics
por: Arnold, David B, et al.
Publicado: (1988)

Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry
por: Gori, Tommaso, et al.
Publicado: (2019)

Definition of acute kidney injury impacts prevalence and prognosis in ACS patients undergoing coronary angiography
por: Weferling, Maren, et al.
Publicado: (2021)

The changing spectrum of cardiovascular emergencies during the COVID-19 pandemic
por: Thiele, Holger, et al.
Publicado: (2023)

Risk-Stratified Cardiovascular Screening Including Angiographic and Procedural Outcomes of Percutaneous Coronary Interventions in Renal Transplant Candidates
por: König, Julian, et al.
Publicado: (2014)

Extension of a Coronary Intramural Hematoma as a Complication of Early Percutaneous Coronary Intervention after Thrombolytic Therapy
por: El-Mawardy, Mohamed, et al.
Publicado: (2013)

Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified
por: Anderson, John E., et al.
Publicado: (2020)

Online Education Improves Knowledge and Confidence Related to CGM and the AGP
por: Larkin, Amy, et al.
Publicado: (2021)

LBODP063 The Benefits Of Using Cgm For Intravenous Insulin Therapy
por: Bublik, Evgeniya, et al.
Publicado: (2022)

Hypoglycemia event prediction from CGM using ensemble learning
por: Fleischer, Jesper, et al.
Publicado: (2022)

Continuous Glucose Monitoring (CGM) in Sports—A Comparison between a CGM Device and Lab-Based Glucose Analyser under Resting and Exercising Conditions in Athletes
por: Bauhaus, Helen, et al.
Publicado: (2023)

Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissions
por: Gitt, A. K., et al.
Publicado: (2020)

Health Care Analysis on Myocardial Revascularization in Patients with Chronic Coronary Artery Disease: The Multicenter REVASK Study: Design and Protocol
por: Beckmann, Andreas, et al.
Publicado: (2020)

Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed
por: Karakuş, Kağan Ege, et al.
Publicado: (2021)

The CGM Experience of Minority Adults With Type 1 Diabetes in the South Bronx
por: Lozada Orquera, Faustina Alejandra, et al.
Publicado: (2021)

Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes
por: Ni, Kevin, et al.
Publicado: (2023)

Assessing non‐adjunctive CGM safety at home and in new markets (ANSHIN)
por: Chao, Christy, et al.
Publicado: (2023)

Sex-specific Inequalities in the Treatment of Severely Calcified Coronary Lesions: A Sub-analysis of the PREPARE-CALC Trial
por: Fitzgerald, Sean, et al.
Publicado: (2023)

COVID-19-Pandemie: Effekte auf die klinische Versorgung von Herz-Kreislauf-Patienten im Frühling 2020
por: Zeymer, Uwe, et al.
Publicado: (2021)

Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry
por: Pahmeier, Kathrin, et al.
Publicado: (2022)

Side Branch Late Thrombosis After Left Main Coronary Artery Crossover Stenting
por: Alotaibi, Sultan, et al.
Publicado: (2022)

Repeat late instent-stenosis after an interval of four years in the same lesion after bare-metal and drug-eluting stent: a case report
por: Towae, Frank, et al.
Publicado: (2009)

Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008)

Lithoplasty-Facilitated Proximal Cap Penetration of a Calcified Chronic Total Occlusion Coronary Lesion
por: Elbasha, Karim, et al.
Publicado: (2022)

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)
por: Moser, Othmar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7u4fedl7lt2heu95qlq7a2jkpl